Ângelo Bezerra de Souza Fede
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ângelo Bezerra de Souza Fede has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Almir Galvão Vieira Bitencourt
Imaging Department A.C.Camargo Cancer Center São Paulo Brazil
1 shared publication - Cynthia Aparecida Bueno de Toledo Osório
Department of Anatomic Pathology, A.C.Camargo Cancer Center, Sao Paulo, Brazil
1 shared publication - Fabiana Baroni Alves Makdissi
AC Camargo Cancer Center, Brazil
1 shared publication - Guilherme Rocha Melo Gondim
A.C. Camargo Cancer Center, Department of Radiation Oncology, São Paulo, Brazil
1 shared publication - José Claudio Casali da Rocha
Department of Oncogenetics, A.C. Camargo Cancer Center, São Paulo 01509-010, Brazil
1 shared publication - Juliana Alves Souza
A.C.Camargo Cancer Center, Brazil
1 shared publication
Latest Publications
- Open Access
- 6 April 2021
- Published by MDPI AG in Clinics and Practice
- Vol. 11 (2) , 205-215
Malignant Phyllodes Tumor of the Breast: A Practice Review
Introduction: Phyllodes tumor (PT) of the breast, particularly malignant phyllodes tumor (mPT), is a rare fibroepithelial neoplasm. A complex diagnosis is based on pathologic, radiologic, and clinical findings, with controversies about what is the best therapeutic strategy. Objective: Our objective was to provide an overview of the clinical, pathologic, and therapeutic aspects of this rare tumor. Conclusions: mPT is a rare presentation of breast cancer and a challenge in clinical practice. A multidisciplinary approach should take into account some aspects like pathogenic mutations and hereditary syndromes. Oncologic surgery is the fundamental approach, and the use of adjuvant therapies is still controversial due to the lack of clinical trials. Treatment recommendations should be individualized according to patient risk and preferences. Prospective studies are fundamental to clarifying the best treatment for these tumors.
- 6 April 2021
- Published by MDPI AG in Clinics and Practice
- Vol. 11 (2) , 205-215
Open AccessMalignant Phyllodes Tumor of the Breast: A Practice Review
Introduction: Phyllodes tumor (PT) of the breast, particularly malignant phyllodes tumor (mPT), is a rare fibroepithelial neoplasm. A complex diagnosis is based on pathologic, radiologic, and clinical findings, with controversies about what is the best therapeutic strategy. Objective: Our objective was to provide an overview of the clinical, pathologic, and therapeutic aspects of this rare tumor. Conclusions: mPT is a rare presentation of breast cancer and a challenge in clinical practice. A multidisciplinary approach should take into account some aspects like pathogenic mutations and hereditary syndromes. Oncologic surgery is the fundamental approach, and the use of adjuvant therapies is still controversial due to the lack of clinical trials. Treatment recommendations should be individualized according to patient risk and preferences. Prospective studies are fundamental to clarifying the best treatment for these tumors.